The coalition said in a statement that “the new deadline is a dramatic improvement of more than two years from the current deadline of August 2022.”

“’It is critical that the FDA use this legally required review process to remove from the market products that appeal to kids and have fueled the youth e-cigarette epidemic.”

The FDA said it plans to accelerate the premarket reviews of products that “are most attractive to youths,” such as flavored products.

Grimm wrote that the “record before me shows a purposeful avoidance by the industry of complying with the premarket requirements despite entreaties from the FDA that it can do so, and it establishes a shockingly low rate of filings.”

“The FDA has made clear that it is willing to work with manufacturers in the interim to provide informal guidance.”

Hong said that with Grimm’s ruling, “we believe the likelihood of a complete and outright ban on Juul is low given the potential negative public health impact that will likely be created as some legal-age smokers have shifted to Juul products.”

“FDA can also include other conditions, such as marketing restrictions, as part of its approval process.”